Susquehanna International Group
NUTX

Susquehanna International Group’s Nutex Health NUTX Stock Holding History

Susquehanna International Group’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420K Buy
2,457
+36
+1% +$4.56K ﹤0.01% 10303
2026
Q1 		$230K Sell
2,421
-1,899
-44% -$233K ﹤0.01% 11436
2025
Q4 		$711K Buy
+4,320
New +$573K ﹤0.01% 7986
2025
Q3 		– Sell
-7,850
Closed -$977K – 13436
2025
Q2 		$977K Sell
7,850
-43,650
-85% -$5.64M ﹤0.01% 7494
2025
Q1 		$2.42M Buy
+51,500
New +$2.51M ﹤0.01% 5111
2024
Q3 		– Sell
-1,148
Closed -$6.83K – 12704
2024
Q2 		$6.83K Buy
+1,148
New +$8.28K ﹤0.01% 11805
2024
Q1 		– Sell
-758
Closed -$20.5K – 12965
2023
Q4 		$20.5K Buy
+758
New +$23.6K ﹤0.01% 11972
2023
Q3 		– Sell
-702
Closed -$44.4K – 12654
2023
Q2 		$44.4K Buy
702
+2
+0.3% +$172 ﹤0.01% 11383
2023
Q1 		$106K Buy
+700
New +$142K ﹤0.01% 11247
2022
Q4 		– Sell
-77
Closed -$17K – 13283
2022
Q3 		$17K Sell
77
-115
-60% -$48.8K ﹤0.01% 12652
2022
Q2 		$93K Buy
+192
New +$226K ﹤0.01% 11542

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Susquehanna International Group's NUTX Position: Q2 2026 in Review

Susquehanna International Group increased its Nutex Health (NUTX) stake by 1.5% in Q2 2026, buying an estimated $4.56K and bringing the position to 2,457 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #10303.

Susquehanna International Group first reported a position in NUTX in Q2 2022 and has held it in 11 quarters since. The position peaked at $2.42M in Q1 2025. 153 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Susquehanna International Group held 2,457 shares of Nutex Health worth $420K as of Q2 2026.
  • Susquehanna International Group bought 36 Nutex Health shares in Q2 2026, an estimated $4.56K.
  • Nutex Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #10303 holding.
  • Susquehanna International Group first reported a position in Nutex Health in Q2 2022 and has held it in 11 quarters since.
  • Susquehanna International Group's Nutex Health position peaked at $2.42M in Q1 2025.
  • 153 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.